Total Payments
$1,009
2020 Payments
$119.54
Companies
6
Transactions
12
Medicare Patients
1,406
Medicare Billing
$97,456
Payment Breakdown by Category
Food & Beverage$998.57 (99.0%)
Education$10.40 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $998.57 | 10 | 99.0% |
| Education | $10.40 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $344.44 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $310.93 | 3 | $0 (2019) |
| Respicardia, Inc. | $119.54 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $108.94 | 1 | $0 (2019) |
| Mylan Specialty L.P. | $108.94 | 1 | $0 (2019) |
| Amgen Inc. | $16.18 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $119.54 | 1 | Respicardia, Inc. ($119.54) |
| 2019 | $459.64 | 5 | AstraZeneca Pharmaceuticals LP ($122.06) |
| 2018 | $111.39 | 2 | AstraZeneca Pharmaceuticals LP ($111.39) |
| 2017 | $318.40 | 4 | Novartis Pharmaceuticals Corporation ($207.41) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/28/2020 | Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $119.54 | General |
| Category: Respiratory | ||||||
| 12/05/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $108.94 | General |
| Category: Respiratory and Allergy | ||||||
| 07/18/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Neuroscience | ||||||
| 06/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $108.94 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $103.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $105.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $105.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $112.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/23/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $94.48 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 17 | 1,406 | 1,690 | $306,715 | $97,456 |
Total Patients
1,406
Total Services
1,690
Medicare Billing
$97,456
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 287 | 533 | $119,392 | $30,664 | 25.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 214 | 214 | $64,628 | $24,050 | 37.2% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 72 | 77 | $30,954 | $7,684 | 24.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 87 | 91 | $7,615 | $5,500 | 72.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 48 | 57 | $17,214 | $5,233 | 30.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 223 | 223 | $8,251 | $3,872 | 46.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 183 | 183 | $6,771 | $3,199 | 47.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 25 | 25 | $4,053 | $2,974 | 73.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 16 | 16 | $6,064 | $2,205 | 36.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 13 | 13 | $5,343 | $2,107 | 39.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 12 | 12 | $5,412 | $2,001 | 37.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2020 | 16 | 17 | $6,834 | $1,747 | 25.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 96 | 100 | $5,200 | $1,614 | 31.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 38 | $5,700 | $1,408 | 24.7% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2020 | 14 | 14 | $3,976 | $1,004 | 25.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 14 | 22 | $4,642 | $932.21 | 20.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 11 | 13 | $2,743 | $545.90 | 19.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 31 | 31 | $1,612 | $499.03 | 31.0% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 11 | 11 | $311.78 | $215.38 | 69.1% |
About Dr. Michael Cottone, MD
Dr. Michael Cottone, MD is a Family Medicine healthcare provider based in Silvis, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013912005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cottone, MD has received a total of $1,009 in payments from pharmaceutical and medical device companies, with $119.54 received in 2020. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($998.57).
As a Medicare-enrolled provider, Cottone has provided services to 1,406 Medicare beneficiaries, totaling 1,690 services with total Medicare billing of $97,456. Data is available for 1 year (2020–2020), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Silvis, IL
- Active Since 06/16/2005
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013912005
Products in Payments
- ENTRESTO (Drug) $310.93
- FARXIGA (Drug) $238.45
- remede System (Device) $119.54
- TRELEGY ELLIPTA (Drug) $108.94
- Yupelri (Drug) $108.94
- BYDUREON (Drug) $105.99
- Aimovig (Biological) $16.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.